Sb Investment Advisers (Uk) LTD Vir Biotechnology, Inc. Transaction History
Sb Investment Advisers (Uk) LTD
- $12.1 Billion
- Q3 2024
A detailed history of Sb Investment Advisers (Uk) LTD transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Sb Investment Advisers (Uk) LTD holds 16,684,041 shares of VIR stock, worth $125 Million. This represents 1.03% of its overall portfolio holdings.
Number of Shares
16,684,041
Previous 16,684,041
-0.0%
Holding current value
$125 Million
Previous $148 Million
15.84%
% of portfolio
1.03%
Previous 1.37%
Shares
6 transactions
Others Institutions Holding VIR
# of Institutions
218Shares Held
87MCall Options Held
127KPut Options Held
1.19M-
Black Rock Inc. New York, NY16.4MShares$123 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$98.1 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$42 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.57MShares$26.7 Million0.63% of portfolio
-
Baillie Gifford & CO2.38MShares$17.8 Million0.01% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $991M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...